Reglitazar is a PPARɑ agonist and PPARγ agonist. Reglitazar rapidly stimulates glucose disposal rates by enhancing insulin signal transduction in skeletal muscle. Reglitazar improves insulin resistance in genetic and non-genetic insulin-resistant models. Reglitazar reverses hypertriglyceridemia in Zucker fatty and ventromedial hypothalamus-lesioned obese rats.

170861-63-9

C22H20N2O5

392.4

JTT-501;PNU-716;PNU182716;JTT501;PNU-182716;Reglitazar

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years